The potential opposing roles of Akt1 and Akt2 in lung tumorigenesis suggest that development of non-selective Akt inhibitors may not be beneficial and in fact, may be detrimental, particularly in the case of lung cancer in never smokers. The gene discussed is AKT1; the disease is lung carcinoma.